Trials find new combination regimen extends survival
Cleveland Clinic study sees benefit for NSCLC patients
Researchers see patient subgroups with higher clot risk
Studies also address survivorship issues
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Learn about featured cancer clinical trials currently enrolling or search our trials database
Study finds redesigned low-dose decitabine regimen terminates cancer growth, produces durable benefits
Cleveland Clinic researchers study new treatments for rare disease
Cell study upends thinking about VEGF-A
Study Suggests Approach to Reduce Ovarian Toxicity While Fighting Breast Cancer
Results could guide further development
Advertisement
Advertisement